1. Poor policy and inadequate regulation of medical technology is driving low-value care in Australia's private health system.
- Author
-
David, Rachel
- Subjects
MEDICAL technology ,GOVERNMENT policy ,PATIENT safety ,MEDICAL care ,COST analysis ,VALUE-based healthcare ,PRIVATE sector ,QUALITY control ,CONFLICT of interests ,QUALITY assurance ,NEURAL stimulation ,RULES ,MEDICAL care costs ,EQUIPMENT & supplies ,SPINAL cord - Abstract
Millions of Australians use the private health system every year. They should receive safe, high-quality, value-based care. However, poor policy and inadequate regulation of medical technology is driving low-value care at great expense to consumers and the broader health system. Key drivers include the Prescribed List of Medical Devices and Human Tissue, gaps in quality and safety controls for devices being used, and marketing and conflicts of interest. All of these should be addressed to reduce low-value care in Australia's private health system, so consumers are protected from harm and limited health budgets are used effectively. What is known about the topic? With health expenditure rising unsustainably, there is a growing focus on ways to reduce low-value care to improve health outcomes and eliminate unnecessary costs. What does this paper add? This paper details drivers of low-value care in Australia's private health system and recommendations to overcome them. Drivers include the Prescribed List of Medical Devices, gaps in safety and quality controls, and conflicts of interest and marketing. What are the implications for practitioners? These insights are relevant to clinicians, researchers, policymakers, consumers and health business leaders with an interest in low-value care. This article belongs to the Special Issue: Value-based Healthcare. [ABSTRACT FROM AUTHOR]
- Published
- 2024
- Full Text
- View/download PDF